CFH and lipoprotein glomerulopathy: A recent study that aimed to investigate the contribution of humoral immunity to the development of glomerulopathy employed CFH deficiency as a model for MPGN and showed that Cfh−/− mice lacking B cells (backcrossed on the B cell-deficient μMT background) were protected from progressive glomerular disease (18).